TLR9 and colitis: DNA from the VSL#3 probiotic formulation induced IL-6 and IL-12p40 secretion in bone marrow-derived macrophages (BMDMs) by activating NF-κB and JNK pathways and protected mice against DSS-induced colitis through a TLR9-MyD88-dependent mechanism [254].